TMEM119 and ovarian carcinoma: Recently, TMEM119 was reported to be overexpressed in ovarian cancer tissues, and expression levels are positively related to the International Federation of Gynecology and Obstetrics (FIGO) stages, suggesting that TMEM119 might be a prognostic biomarker.